Clinical Trial Update: Single Dose of 9-cis-retinoic Acid in Hepatic Patients

View source ↗

Summary

A completed clinical trial evaluating a single dose of 9-cis-retinoic acid in patients with hepatic insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Drugs mentioned

• 9-cis-retinoic acid (9-cis-retinoic acid)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Hepatic Insufficiency | Status: COMPLETED